Delivery Order SPE2DB22D2211-SPE2DB23FPAR2
Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $19
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from August 7-8, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger governmentwide acquisition...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance over a one day period from August 1-2, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders against its Prime...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $18,880 firm fixed price delivery order by the Defense Logistics Agency to provide 50 milligram/2 milliliter vials of methotrexate. The single day contract has a period of performance from August 24, 2023 through August 25, 2023. To be performed in Conshohocken, Pennsylvania, this delivery order is issued against an existing DLA pharmaceuticals contract vehicle and will supply the agency with...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $40,900 firm fixed price delivery order by the Defense Logistics Agency to provide 4562172665 units of methotrexate 50 mg/2 ml vials. The single day contract has a period of performance from September 14 to 15, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for worldwide logistics support of...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $37,760 firm fixed price delivery order by the Defense Logistics Agency to supply 50 mg/2 ml vials of methotrexate. The single day contract issued on September 21, 2023 calls for Amerisourcebergen to deliver the chemotherapy drug to a location in Conshohocken, Pennsylvania by September 22, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $18,880 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4561926738, methotrexate 50 mg/2 ml vials packaged in 2 ml quantities. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 24-25, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $37,760 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from September 7-8, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The Defense Logistics Agency utilizes contracts such as this to procure pharmaceuticals in support of...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at ten thousand five hundred forty dollars by the Defense Logistics Agency to provide fifty milligrams per two milliliters vials of methotrexate. The firm fixed price order is associated with the DLA's pharmaceutical procurement program and has a period of performance from August 10th to 11th, 2023 in Conshohocken, Pennsylvania. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $69,370 to Amerisourcebergen Drug Corporation for the supply of 1 gram/40mL vials of methotrexate. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to locations within Conshohocken, Pennsylvania by August 30, 2023 in fulfillment of DLA requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,957.04 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 tablets of 2.5 mg Methotrexate. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by December 7, 2023. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified....
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPAR2Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania under an existing DLA pharmaceuticals contract vehicle. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to support the DLA's medical supply needs for the Department of Defense without use of subcontractors.
Generated 12/19/23, 5:38 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19 | 8/24/23 |